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Purpose: Mutations in the paired box 6 (PAX6) gene cause a wide variety of eye anomalies, including aniridia. PAX6
mutations are not well described in the Chinese population so this study is aimed at exploring the role of PAX6 mutations
in Taiwanese patients with congenital eye anomalies.
Methods: Seventeen patients with single or multiple congenital eye anomalies were enrolled. Genomic DNA was prepared
from venous blood leukocytes, and the coding regions of PAX6 were analyzed by PCR and direct sequencing. Clinical
manifestations of the patients were then correlated to PAX6 mutations.
Results: Five PAX6 mutations were identified in one case each. Three mutations c.317T>A (p.L106X), c.142–1G>T, and
c.656del10 (p.Q219QfsX20) were novel and the other two, c.331delG (p.V111SfsX13) and c.949C>T (p.R317X), have
been reported. All five cases had aniridia; three had other eye anomalies; and four had developmental delay. Only one
case had other affected family members. In the ten cases that had no PAX6 mutation, only one had aniridia.
Conclusions: Both novel and known PAX6 mutations were identified in the current study, and PAX6 mutations were
closely associated with aniridia. Absence of a positive family history does not exclude PAX6 mutation. The frequent
occurrence of developmental delay in patients with PAX6 mutation argues for a prompt diagnosis of the disease.
Aniridia is a rare ocular anomaly characterized by defects
of iris tissue, ranging from mild iris hypoplasia to almost total
absence of iris [1]. It occurs with an incidence of 1:64,000 to
1:100,000  [2,3].  Two-thirds  of  the  cases  show  autosomal
dominant inheritance with complete penetrance, while others
are sporadic [3–5]. Clinical manifestations of patients varied
from  isolated  iris  involvement  to  panocular  anomalies
involving  the  cornea  (opacity),  anterior  chamber  angle
(glaucoma), lens (dislocation and/or cataracts), retina (foveal
dysplasia),  and  macular  and  optic  nerve  (hypoplasia)  [2].
Aniridia  can  be  associated  with  Wilms  tumor;  aniridia,
genitourinary  disorders,  and  mental  retardation  (WAGR
syndrome); Gillespie syndrome (aniridia, cerebellar ataxia,
and  mental  deficiency);  absent  patella;  unilateral  renal
agenesis  and  mild  psychomotor  retardation;  congenital
adrenal hypoplasia and dysmorphism; sensorineural deafness;
Marfan  syndrome;  Smith-Opitz  syndrome;  Biemond
syndrome; XXXXY chromosomal anomalies; or Badet–Biedl
syndrome [2,6–13].
Several genes, including the paired box 6 (PAX6), paired-
like  homeodomain  2  (PITX2/RIEG1),  forkhead  box  C1
(FOXC1/FKHL7), SIX homeobox 3 (SIX3), HESX homeobox
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1 (HESX1/RPX), paired-like homeodomain 3 (PITX3), cone-
rod  homeobox  (CRX),  guanylate  cyclase  2D,  membrane
(retina-specific; GUCY2D/RETGC1), peripherin 2 (PRPH/
RDS),  retinal  pigment  epithelium-specific  protein  65kDa
(RPE65),  paired  box  2  (PAX2),  paired  box  3  (PAX3),
microphthalmia-associated  transcription  factor  (MITF),
jagged  1  (JAG1),  and  retina  and  anterior  neural  fold
homeobox  (Rx),  and  FOXC1,  are  important  for  eye
embryogenesis      [ 1,14,15 ].    Among        them,      PAX6,
PITX2, FOXC1,  and  FLHL7   are  associated   with   iris
defects. Haploinsufficiency or dominant negative mutation of
PAX6 leads to aniridia, congenital cataract, Peter’s anomaly,
Gillespie  syndrome,  and  midline  fusion  defects,  while
complete deficiency of PAX6 leads to anophthalmia [1,3,4].
Mutations of PITX2 result in Rieger’s syndrome (anterior
segment abnormalities, glaucoma, tooth anomalies, umbilical
stump abnormalities); mutations of FOXC1 result in Rieger’s
syndrome  (type  3);  mutations  of  FKHL7  cause  anterior
segment  anomaly  with  glaucoma  (abnormal  iridocorneal
angle differentiation, iris stromal hypoplasia, and elevated
intraocular pressure/glaucoma) [1,14–17].
PAX6  is  a  transcriptional  regulator  in  the  early
development in the ocular system, central nervous system, and
gastrointestinal system [5,18]. This gene contains 14 exons
and encodes a 422-amino acid polypeptide containing two
DNA-binding  domains,  a  bipartite  paired  domain,  and  a
paired type homeodomain [4]. The paired domain, which is
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2139coded  by  exons  5–7  of  PAX6,  has  two  subdomains:  the
relatively conserved 74-amino acid NH2-terminal subdomain
and  the  more  divergent  54-amino  acid  COOH-terminal
subdomain.  The  latter  subdomain  is  a  common  place  for
mutations [4,19]. Currently there are around 500 mutations
that  have  been  reported  (Human  PAX6  Allelic  Variant
Database [HPAVD]) [20]. Most PAX6 nonsense mutations
lead to aniridia, while missense mutations are related to foveal
hypoplasia,  congenital  cataracts,  or  anterior  segment
anomalies [21,22].
There has been no systemic study for PAX6 mutations in
the Chinese population [23–25]. In this study, we analyzed the
coding sequences of PAX6 in 17 patients with eye anomalies.
Three novel and two known heterozygous mutations were
detected. Only one patient had other affected family members,
but intrafamilial variation was prominent.
METHODS
From 2003 to 2009, 17 patients (nine males and eight females)
with single or multiple congenital eye anomalies diagnosed in
two  hospitals  were  enrolled  in  the  study  after  informed
consent.  They  were  healthy  except  for  their  eye  and
neurological deficits. The study protocol included slit lamps
and neurological examinations, brain Magnetic Resonance
Imaging (MRI), pedigree analysis, and PAX6 gene analysis.
Genomic DNA was isolated from 5 milliliters of venous blood
using  a  QIAamp  DNA  blood  mini  kit  (Qiagen®,  Hilden,
Germany). PAX6 coding regions and their flanking intronic
sequences  were  amplified  by  PCR  (Table  1).  The  PCR
products were purified by Gel-MTM Gel Extraction System
(Viogene®,  Taipei,  Taiwan)  and  analyzed  by  direct
sequencing  using  the  ABI  Prism  Big  Dye  dideoxy  chain
terminator cycle sequencing kit and the ABI Prism 310 genetic
analyzer (Applied Biosystem, Foster City, CA). PAX6 cDNA
was  numbered  starting  from  the  translation  initiation  site
(NM_000280.3). Mutations were confirmed by sequencing
from the opposite strand and by co-segregation of the lesion
and disease within the family. Phenotypes of the patients were
retrieved from the medical charts. Clinical manifestations of
patients were then correlated to PAX6 mutations.
RESULTS
Of the 17 indexed patients, five had PAX6 mutations. All five
patients had aniridia, and two of them had fovea hypoplasia
(Table 2). The five heterozygous mutations are c.142–1G>T,
c.317T>A  (p.L106X),  c.331delG  (p.V111SfsX13),  c.
656del10 (p.Q219QfsX20), and c.949C>T (p.R317X) (Table
2). Mutation c.949C>T and c.331delG have been reported
previously  [26].  C.949C>T  is  widespread  in  different
countries,  while  c.331delG  is  found  only  in  the  USA.
Mutation c.317T>A, c.142–1G>T, and c.656del10 have not
been  previously  reported.  Both  c.317T>A  and  c.656del10
produce prematurely stopped polypeptides. Mutation c.142–
1G>T is located at the splicing consensus sequence of intron
5b and is likely to produce splicing errors similar to reported
mutations c.141+1 G>A, c.141+2T>C, and c.142–2A>G [20,
27].
Among the five patients, only patient 2 had other affected
family members. He and his mother accepted PAX6 gene
analysis and both of them had the c.949C>T mutation (Figure
1.  V-2,  IV-2).  There  were  eight  individuals  in  this  four-
generation family who had congenital eye anomalies (Figure
1).  Their  anomalies  included  bilateral  aniridia,  cataract,
glaucoma, and jerk horizontal nystagmus (Figure 1). They all
had intact retina, choroids, and optic nerve. All other patients,
except  patient  2,  were  sporadic.  Interestingly,  four  cases
(patient  2  to  5)  had  delays  in  gross  motor,  fine  motor,
language, and cognition to a variable extent. Patient 2 could
not sit until 10 months of age and started babbling only after
1  year  of  age.  After  the  correction  of  a  congenital  hip
dislocation and aggressive physical therapy, he walked at 19
months of age and climbed stairs with assistance at the age of
2 years. Pincer grasp was not observed until 12 months of age.
Patient 3 walked with support at the age of 13 months and said
TABLE 1. PRIMERS USED TO AMPLIFY THE PAX6 GENE.
Amplified
length (bp) Forward primer (5’ to 3’) Reverse primer (5’ to 3’)
1 645 GCATGTTGCGGAGTGATTAG CTCCTGCGTGGAAACTTCTC
2 645 GCATGTTGCGGAGTGATTAG CTCCTGCGTGGAAACTTCTC
3 676 AGAGAGCCCATGGACGTATG GTCGCGAGTCCCTGTGTC
4 676 AGAGAGCCCATGGACGTATG GTCGCGAGTCCCTGTGTC
5 373 TGAGGATGCATTGTGGTTGT GAAATGAAGAGAGGGCGTTG
6 388 CGTAAGCTTGTCATTGTTTAATGC AGAGAGGGTGGGAGGAGGTA
7 333 GGTTGTGGGTGAGCTGAGAT AAGCCCTGAGAGGAAATGGT
8 355 GGCTGTCGGGATATAATGCT CAAAGGGCCCTGGCTAAAT
9 385 AGGTGGGAACCAGTTTGATG TGGGACAGGTTAGCACTGTGT
10 537 AGCAGTGGAGGTGCCAAG TCTCAAGGGTGCAGACACAG
11 537 AGCAGTGGAGGTGCCAAG TCTCAAGGGTGCAGACACAG
12 345 CAGACTTGTTGGCAGAGTTCC TAAACACGCCCTCCCATAAG
13 373 TTTCTGAAGGTGCTACTTTTATTTG CGGCTCTAACAGCCATTTTT
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2141“papa” and “mama” at 21 months. His brain echo was normal.
Patient 4 was noted to have a small subependymal cyst at birth
and head lag at age 4 months, but he did not return for follow
up thereafter. Patient 5 could not sit up or turn over at the age
of 7 months.
Phenotypes of the 12 PAX6 mutation-negative cases are
summarized in Table 3. Only one of the 12 cases without
PAX6  mutation  had  aniridia.  Five  of  them  had
microphthalmos, three had dysmorphic facial features, and
two had developmental delay.
DISCUSSION
In this study we identified five PAX6 mutations in 17 patients
with  congenital  eye  anomalies,  resulting  in  a  mutation
Figure 1. Pedigree of patient 2. The pedigree has been modified for
privacy  by  changing  the  sequence  of  the  family  members.  DD,
developmental delay; DDH, Developmental dysplasia of hip
detection rate of approximately 30% (5/17) in all patients with
congenital  eye  anomalies  or  83%  (5/6)  in  patients  with
aniridia.  Our  detection  rate  is  comparable  with  previous
reports that 30%–80% of patients with aniridia have PAX6
mutations [28–30].
There were eight reports, four in English and four in
Chinese, each mentioned a PAX6 mutation in one Chinese
family with aniridia. The reported mutations, including c.
1286delC  (c.924delC),  c.483del9  (c.121_129del9),
IVS10+1G>A,  c.1080C>T  (c.718C>T),  and  c.857delG  (c.
495delG) [23,24,31–36], surprisingly none occurred in our
population.  That  each  mutation  occurs  independently
demonstrates the great diversity of PAX6 mutations in the
Chinese population. The large proportion of sporadic cases in
the  current  study  also  suggests  the  diversity  of  PAX6
mutations.
In  our  cohort,  80%  (4/5)  of  patients  with  the  PAX6
mutation had developmental delay. This high incidence of
developmental delay is unexpected. Patients with aniridia and
neurologic problems were more linked to WAGR syndrome
(75%  have  mental  retardation),  Gillespie’s  syndrome,
chromosome anomalies, or PAX6 gene duplication [2,4,37–
39].  Although  we  did  not  exclude  large  fragment  gene
deletions  in  the  current  study,  none  of  our  patients  had
syndromic  aniridia.  Deletions  not  detectable  by  DNA
sequencing and associated with isolated aniridia have been
reported, but they are present only in a small fraction of
patients [40,41].
Several PAX6 mutations have been associated with mild
mental  retardation  (c.-129+2T>A,  c.111_141ins,  R44X,
S74G, I87R, S119R, Q135X, W257X, C719A, c.1267dupT,
and 1.3 Mb deletion from 3′ UTR of PAX6 gene at 11p14.1-
p13) [20,29,42–46]. One patient with c.-129+2T>A mutation
TABLE 3. PHENOTYPES OF PATIENTS WHO HAVE EYE ANOMALIES BUT NO PAX6 MUTATION.
Associated organ Phenotypes Number of cases*
Eye Microphthalmos 5
  Microcornea 2
  Eyelid coloboma 2
  non-specified eye anomaly 2
  Aniridia 1
  Cornea whitish plague, Congenital cataract, Choridal
coloboma, Anophthalmos, Strabismus
One each
Central nervous system Developmental delay 2
  Ventriculomegaly 2
  Periventricular cyst, Hemiparesis, Seizure, Corpus
callosum hypoplasia
One each
Genitourinary Small kidney 2
  Vesiculoureteral reflux, Cryptorchidism One each
Cardiac Coarctation of aorta, Patent ductus arteriosus One each
Skeletal Congenital hip dislocation 1
Others Dysmorphism 3
  Choanal atresia, Transient congenital hypothyroidism One each
The total number of patients = 12
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2142had hand tremors and learning disabilities [6]; a boy with c.
111_141ins had intellectual impairment [29]; microcephaly,
developmental delay, and several minor dysmorphic features
were noted in the sporadic patient with I87R mutation [20];
one  large  family  with  S74G  mutation  showed
neurodevelopmental defects with or without other associated
brain  anomalies  [46].  Occasionally,  mental  retardation
occurred in only a portion of the affected family members
[20,42]. In the Human PAX6 Allelic Variant Database, one of
the three cases with S119R mutation had a learning disability
and behavioral change; one of the 20 cases with c.1267dupT
mutation  was  recorded  to  have  developmental  delay  and
autistic behavior. The mutations discovered in our series (c.
142–1G>T, c.317T>A, c.949C>T, c.331delG, and c.656del110)
are  different  from   these  reported   cases  with   mental
retardation. However the mild developmental delay in this
study could have been neglected by other studies  because
of the vision problems of patients. The global delay in case
2  could  not  be  explained  by his vision problem or hip
dislocation.  Other cases in the current study also involved
only gross motor or speech problems, which were difficult
to explain by poor visual activity.
PAX6 gene expression is seen after the end of gastrulation
in the anterior neural plate [15]. In a mouse model, Pax6 is
widely expressed in the developing eye (optic cup, lens, and
overlying surface ectoderm) and in specific regions of the
developing  brain  (frontal  cortex,  epithalamus,  ventral
tagmental area, pons, external granular layer of cerebellum,
fovea  isthmi,  olfactory  bulb,  septum,  olfactory
neuroepithelium) [47,48]. PAX6 has been suggested as being
expressed in conjunction with other PAX family members in
the early regionalization of the brain [47,48]. Recently, the
interactions of Pax6 with developing neocortex transcription
factors T-box brain gene 1 (Tbr1), eomesodermin homolog
(Tbr2),  neurogenin  2  (Ngn2)  and  achaete-scute  complex
homologue 1 (Mash-1) further demonstrate the role of PAX6
in the developing neocortex [49–51]. The PAX6 heterozygous
mouse has absent olfactory bulb, decreased cortical neurons
and  cortical  plate  thickness,  and  altered  dorsoventral
patterning  of  the  forebrain  [45].  In  patients  with  PAX6
mutation, polymicrogyria, absence of pineal gland, and lack
of the anterior commisure have all been reported [52,53].
Therefore, it is possible that patients with PAX6 mutation have
neurologic manifestations.
In conclusion, we demonstrated the mutation spectrum
and neurologic manifestations of patients with PAX6 mutation
in Chinese. Most patients with aniridia had PAX6 mutations.
Other associated problems, such as developmental delay and
even  congenital  hip  dislocations,  may  also  be  important.
Therefore,  detailed  neurologic  examination  and  close
observation of development is important for patients with
aniridia. Early institution of physical therapies for patients
with developmental delay should be able to improve their
long-term prognosis.
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